Anti-Third Party CD8+ CTLs as Potent Veto Cells: Coexpression of CD8 and FasL Is a Prerequisite
- 1 October 2000
- Vol. 13 (4) , 507-515
- https://doi.org/10.1016/s1074-7613(00)00050-9
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The Role of Megadose CD34+ Progenitor Cells in the Treatment of Leukemia Patients without a Matched Donor and in Tolerance Induction for Organ TransplantationAnnals of the New York Academy of Sciences, 1999
- BLOCKADE OF MULTIPLE COSTIMULATORY RECEPTORS INDUCES HYPORESPONSIVENESSTransplantation, 1996
- Hybrid antibody mediated veto of cytotoxic T lymphocyte responses.The Journal of Experimental Medicine, 1996
- Bone marrow transplantation across HLA barriers by increasing the number of transplanted cellsImmunology Today, 1995
- The level of CD8 expression can determine the outcome of thymic selectionCell, 1992
- Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes.The Journal of Experimental Medicine, 1992
- Programmed Cell Death of T Cells Signaled by the T Cell Receptor and the α 3 Domain of Class I MHScience, 1991
- Functional Heterogeneity in Allospecific Cytotoxic T Lymphocyte ClonesScandinavian Journal of Immunology, 1989
- Veto CellsAnnual Review of Immunology, 1988
- An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing itNature, 1980